|
Genentech inc
k63-ub (human monoclonal) genentech c-apu3.a8 K63 Ub (Human Monoclonal) Genentech C Apu3.A8, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+a8c+against+mrsa/pmc06826192-36-6-4?v=Genentech+inc Average 90 stars, based on 1 article reviews
k63-ub (human monoclonal) genentech c-apu3.a8 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
BioResource International Inc
c. elegans itsn-1 C. Elegans Itsn 1, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+a8c+against+mrsa/pmc03791081-50-26-61?v=BioResource+International+Inc Average 90 stars, based on 1 article reviews
c. elegans itsn-1 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Verlag GmbH
a8 A8, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+a8c+against+mrsa/10__1002_slash_prop__201520005-25-8-4?v=Verlag+GmbH Average 90 stars, based on 1 article reviews
a8 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Gallus BioPharmaceuticals
gly115arg ![]() Gly115arg, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+a8c+against+mrsa/pmc05528405-450-105-79?v=Gallus+BioPharmaceuticals Average 90 stars, based on 1 article reviews
gly115arg - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
SHOFU INC
electrolyte solution (h2so4 10) ![]() Electrolyte Solution (H2so4 10), supplied by SHOFU INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+a8c+against+mrsa/pm22447067-50-21-25?v=SHOFU+INC Average 90 stars, based on 1 article reviews
electrolyte solution (h2so4 10) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ATCC
compound a8c against mrsa ![]() Compound A8c Against Mrsa, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+a8c+against+mrsa/10__1111_slash_cbdd__14554-40-7-11?v=ATCC Average 99 stars, based on 1 article reviews
compound a8c against mrsa - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Molecular Oncology
Article Title: Polymorphic variations in the FANCA gene in high‐risk non‐BRCA1/2 breast cancer individuals from the French Canadian population
doi: 10.1016/j.molonc.2012.08.002
Figure Lengend Snippet: Sequence variations in FANCA gene and genotype frequencies in familial breast cancer cases and controls.
Article Snippet: Therefore, the Thr561Met and Cys625Ser amino acid changes are predicted to be damaging for protein function by all three programs and most of the changes leading to a potential deleterious effect identified by at least one of the programs used, are located in important domains or binding sites such as the BRCA1 binding site region (aa 1–589) or the Leucine zipper domain (aa 1069–1090). table ft1 table-wrap mode="anchored" t5 caption a7 SNPa SNP IDb Amino acid change Macaca mulatta
Techniques: Sequencing
Journal: Molecular Oncology
Article Title: Polymorphic variations in the FANCA gene in high‐risk non‐BRCA1/2 breast cancer individuals from the French Canadian population
doi: 10.1016/j.molonc.2012.08.002
Figure Lengend Snippet: Non‐synonymous sequence variants detected in human FANCA protein and residues found in orthologues.
Article Snippet: Therefore, the Thr561Met and Cys625Ser amino acid changes are predicted to be damaging for protein function by all three programs and most of the changes leading to a potential deleterious effect identified by at least one of the programs used, are located in important domains or binding sites such as the BRCA1 binding site region (aa 1–589) or the Leucine zipper domain (aa 1069–1090). table ft1 table-wrap mode="anchored" t5 caption a7 SNPa SNP IDb Amino acid change Macaca mulatta
Techniques: Sequencing
Journal: Molecular Oncology
Article Title: Polymorphic variations in the FANCA gene in high‐risk non‐BRCA1/2 breast cancer individuals from the French Canadian population
doi: 10.1016/j.molonc.2012.08.002
Figure Lengend Snippet: Non‐synonymous amino acid changes identified in FANCA protein and prediction of the substitution on protein function using SIFT, PolyPhen and Align GVGD softwares.
Article Snippet: Therefore, the Thr561Met and Cys625Ser amino acid changes are predicted to be damaging for protein function by all three programs and most of the changes leading to a potential deleterious effect identified by at least one of the programs used, are located in important domains or binding sites such as the BRCA1 binding site region (aa 1–589) or the Leucine zipper domain (aa 1069–1090). table ft1 table-wrap mode="anchored" t5 caption a7 SNPa SNP IDb Amino acid change Macaca mulatta
Techniques: Binding Assay